JBM Healthcare Announces FY2025 Interim Results
KEY HIGHLIGHTS – Revenue up by 22.1% to HK$399.0 million– Gross profit increased by 20.3% to HK$205.9 million– Consolidated profit attributable to equity shareholders grew by 53.4% to HK$95.9 million– Interim dividend of HK5.50 cents per share, up by 59.4% year-on-year– Flagship proprietary brands Ho Chai Kung and Po Chai Pills achieved robust growth through […]